FDAClass IINovember 8, 2023

Coapt ControlSeal Electrode recall

Coapt ControlSeal Electrode, cutaneous EMG Electrode

Why was Coapt ControlSeal Electrode recalled?

Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

UDI/DI: +B618P1/$+202210P1603, All serial numbers

Product
Coapt ControlSeal Electrode, cutaneous EMG Electrode
Recalling firm
Coapt LLC
Quantity
109 devices
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Canada, and Sweden.
Recall date
November 8, 2023
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls